Medicure (TSXV:MPH) Cash Flow for Dividends: C$0.00 Mil (TTM As of Mar. 2026)


TSXV:MPH Medicure Inc TSXV:MPH
64 GF Score
Price C$1.28
GF Value C$1.55
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Medicure Cash Flow for Dividends?

Medicure TSXV:MPH 64 Cash Flow for Dividends is C$0.00 Mil as of Mar. 2026. GuruFocus rates TSXV:MPH with a GF Score™ of 64/100 and a GF Value™ of C$1.55 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Medicure's cash flow for dividends for the three months ended in Mar. 2026 was C$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Medicure Cash Flow for Dividends Related Terms

Medicure Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Medicure's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure Cash Flow for Dividends Chart

Medicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medicure Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSXV:MPH
64GF Score
Medicure Inc TSXV:MPH
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicure Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of C$0.00 Mil mean?
Medicure (TSXV:MPH) has a Cash Flow for Dividends of C$0.00 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Medicure and its competitors.
Is Medicure's Cash Flow for Dividends too high?
Medicure's current Cash Flow for Dividends is C$0.00 Mil. Overall, Medicure has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medicure's Cash Flow for Dividends compare to ZTS?
Medicure's Cash Flow for Dividends of C$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Medicure and its competitors. Medicure's current Cash Flow for Dividends is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicure stock overvalued right now?
Based on GuruFocus' analysis, Medicure (TSXV:MPH) is currently considered Modestly Undervalued. The stock's GF Value™ is C$1.55, compared to a current price of C$1.28 — trading 17.4% below its estimated fair value. The current Cash Flow for Dividends is C$0.00 Mil. Medicure's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Medicure (TSXV:MPH), the current Cash Flow for Dividends is C$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicure (TSXV:MPH) Overvalued in 2026?

Based on GuruFocus' analysis, Medicure stock appears to be undervalued. The current stock price of C$1.28 is trading 17.4% below its estimated GF Value™ of C$1.55. GuruFocus considers Medicure to be Modestly Undervalued.

Key valuation signals for TSXV:MPH:

  • Cash Flow for Dividends: C$0.00 Mil
  • GF Value™: C$1.55 vs. price of C$1.28 (17.4% below fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the TSXV:MPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicure Business Description

Other Exchanges MCUJF:USA
Address 1250 Waverley Street, No. 2, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
64GF Score

Get the complete analysis for TSXV:MPH

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.28
Price
C$1.55
GF Value